RADIOTHERAPEUTIC PARAMETERS PREDICTIVE OF LIVER COMPLICATIONS INDUCED BY LIVER TUMOR RADIOTHERAPY

被引:47
作者
Lee, Ik Jae
Seong, Jinsil [1 ]
Shim, Su Jung
Han, Kwang Hyub [2 ]
机构
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Yonsei Liver Canc Clin, Inst Gastroenterol, Seoul 120752, South Korea
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 73卷 / 01期
关键词
Hepatocellular carcinoma; Radiotherapy; Liver complications; CONFORMAL RADIATION-THERAPY; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PRIMARY HEPATOBILIARY CANCERS; LOCAL RADIOTHERAPY; NORMAL-TISSUE; CIRRHOTIC-PATIENTS; HEPATIC TOXICITY; DISEASE; CHEMOTHERAPY;
D O I
10.1016/j.ijrobp.2008.04.035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to identify radiotherapeutic parameters for predicting the occurrence of liver complications induced by radiotherapy of a liver tumor. Methods and Materials: From 2001 to 2003, a total of 131 patients with hepatocellular carcinoma received three-dimensional conformal radiotherapy. The total dose was determined by the fraction of nontumor liver receiving 50% of the isocenter dose (V-50%). We evaluated three sets of published radiation dose guidelines using nontumor liver volume or a combination of nontumor liver volume and hepatic functional reserve. The V-50% was divided into three intervals (<33%,33-66%, and >66%) and four categories (<25%, 25-49%,50-75%, and >75 %) according to guidelines by the University of Michigan and the Yonsei University, respectively. According to the guideline of Cheng et al., the radiation dose was determined by the indocyanin green retention rate at 15 min (ICG-R15) and the nontumor liver volume. Results: Of the 131 patients, 13 patients (9.9%) presented with liver complications. The incidence was 11.1 %, 10.3%, and 18.2%, respectively, for a VS, of less than 33%, 33% to 66%, and more than 66%. The observed hepatic toxicity incidence was 10%, 12.1%, and 10.4% respectively for a VS, of less than 25%, 25% to 49%, and 50% to 75%, respectively. Nontumor liver volume and ICG-R15 were not predictors of liver complications. The incidence of liver complications was significantly increased in patients with Child-Pugh Class B (p = 0.044). Conclusions: The parameter, V-50% can be divided into 4 categories and used to predict acceptable toxicity. Furthermore, indicators of liver functional status like the Child-Pugh class may be more important and useful parameters than ICG-R15 for predicting radiation-related liver disease. (C) 2009 Elsevier Inc.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 31 条
[1]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[2]   The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model [J].
Cao, Yue ;
Platt, Joel F. ;
Francis, Isaac R. ;
Baiter, James M. ;
Pan, Charlie ;
Normolle, Daniel ;
Ben-Josef, Edgar ;
Ten Haken, Randall K. ;
Lawrence, Theodore S. .
MEDICAL PHYSICS, 2007, 34 (02) :604-612
[3]  
Chen Long-hua, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P260
[4]   Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease [J].
Cheng, JCH ;
Wu, JK ;
Lee, PCT ;
Liu, HS ;
Jian, JJM ;
Lin, YM ;
Sung, JL ;
Jan, GJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05) :1502-1509
[5]   Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description [J].
Cheng, JCH ;
Wu, JK ;
Huang, CM ;
Huang, DY ;
Cheng, SH ;
Lin, YM ;
Jian, JJ ;
Yang, PS ;
Chuang, VP ;
Huang, AT .
RADIOTHERAPY AND ONCOLOGY, 2002, 63 (01) :41-45
[6]   A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma [J].
Cheng, SH ;
Lin, YM ;
Chuang, VP ;
Yang, PS ;
Cheng, JCH ;
Huang, AT ;
Sung, JL .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (10) :1025-1033
[7]  
COCHRANE AMG, 1977, CANCER-AM CANCER SOC, V40, P609, DOI 10.1002/1097-0142(197708)40:2<609::AID-CNCR2820400203>3.0.CO
[8]  
2-L
[9]  
Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8
[10]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122